Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 11Plasma cell 9Lymphoid 9Myeloid 8Other neoplasm 2Classical hematology 2

Conditions

Leukemia, Myeloid, Acute 30Anemia, Refractory, with Excess of Blasts 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Myelodysplastic Syndromes 19Leukemia, Myelogenous, Chronic, BCR-ABL Positive 19Multiple Myeloma 16Hodgkin Disease 16Anemia, Aplastic 16Lymphoma, Non-Hodgkin 15Leukemia, Lymphocytic, Chronic, B-Cell 15Myeloproliferative Disorders 12Lymphoma 11Primary Myelofibrosis 10Hematologic Neoplasms 10Leukemia 9Lymphoma, Mantle-Cell 6Lymphoma, Follicular 6Lymphoma, B-Cell, Marginal Zone 5Leukemia, Myelomonocytic, Chronic 5Polycythemia Vera 4Immunologic Deficiency Syndromes 4Hemoglobinopathies 4Fanconi Anemia 4Burkitt Lymphoma 4Blast Crisis 4Anemia, Sickle Cell 4Anemia, Refractory 4Anemia 4Thalassemia 3Recurrence 3

Interventions

Cyclophosphamide 4fludarabine phosphate 2fludarabine 2Stem Cell Transplantation 2Platelet Transfusion 2Mycophenolic Acid 2Mesna 2Melphalan 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Bone Marrow Transplantation 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2venetoclax 1cedazuridine 1Thiotepa 1Tacrolimus 1Sertraline 1Rituximab 1Observation 1Methotrexate 1Cyclosporine 1Cholecalciferol 1Brentuximab Vedotin 1Biopsy 1Azacitidine 1Aspirin 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hematologic Diseases × fludarabine × Classical hematology × Clear all
NCT01010217 2020-03-25

Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide

M.D. Anderson Cancer Center

Phase 2 Completed
176 enrolled 18 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Hematologic Diseases, Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00636909 2017-04-06

MINI HEME

Beth Israel Deaconess Medical Center

Phase 2 Completed
25 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Blast Crisis, Hematologic Diseases, Hodgkin Disease, Multiple Myeloma, Myeloproliferative Disorders, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡